| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARQT | Common Stock | Options Exercise | $657 | +391 | +0.21% | $1.68* | 182K | Jul 1, 2021 | Direct | F1, F2 |
| transaction | ARQT | Common Stock | Options Exercise | $1.31K | +781 | +0.43% | $1.68* | 183K | Jul 1, 2021 | Direct | F1, F2 |
| transaction | ARQT | Common Stock | Options Exercise | $6.7K | +1.03K | +0.56% | $6.52 | 184K | Jul 1, 2021 | Direct | F1, F2 |
| transaction | ARQT | Common Stock | Sale | -$50.8K | -1.95K | -1.06% | $26.03 | 182K | Jul 1, 2021 | Direct | F1, F2, F3 |
| transaction | ARQT | Common Stock | Sale | -$6.72K | -250 | -0.14% | $26.87 | 182K | Jul 1, 2021 | Direct | F1, F2, F4 |
| holding | ARQT | Common Stock | 25K | Jul 1, 2021 | By Trust | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARQT | Stock Option (Right to Buy) | Options Exercise | $0 | -391 | -3.45% | $0.00 | 10.9K | Jul 1, 2021 | Common Stock | 391 | $1.68 | Direct | F6 |
| transaction | ARQT | Stock Option (Right to Buy) | Options Exercise | $0 | -781 | -3.23% | $0.00 | 23.4K | Jul 1, 2021 | Common Stock | 781 | $1.68 | Direct | F6 |
| transaction | ARQT | Stock Option (Right to Buy) | Options Exercise | $0 | -1.03K | -9.44% | $0.00 | 9.86K | Jul 1, 2021 | Common Stock | 1.03K | $6.52 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | Includes 6,750 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. |
| F3 | The transaction was executed in multiple trades in prices ranging from $25.70 to $26.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The transaction was executed in multiple trades in prices ranging from $26.76 to $27.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F5 | The securities are held of record by The Welgus Living Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. |
| F6 | The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. |
| F7 | The option vests monthly over a four year period beginning November 20, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. |